Delivery Order SPE2DB20D3505-SPE2DB25FT9F2
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,917.56, is for the delivery of Gralise ER 600 mg tablets to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,046.86, is a delivery order for the supply of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,508.94, is for the delivery of GRALISE ER 600 MG TABLET 90S, a medication used to treat various conditions. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The...
This federal contract award, with ID SPE2DX15D3015|SPE2DX24F0DB1, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,111.80, is for the delivery of GRALISE ER 600 MG TABLET 90S, a medical product. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award (SPE2DB22D2006|SPE2DB25FV6CD) is a delivery order valued at $12,962.54 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a potential value of $4,064.50. The contract has a firm fixed price pricing type and is a delivery order with a completion date of February 13, 2024....
This federal contract award is for medical supplies, specifically Gralise ER 600 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,478.55 and is a Delivery Order, with a Firm Fixed Price pricing type. The award has an ultimate completion date of December 19, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the pharmaceutical product Gralise ER 600 mg Tablet, with a ceiling value of $15,846.57 and a period of performance through March 11, 2024. Amerisourcebergen Drug Corp has received numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,799.72 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication product. The contract, which has a period of performance ending on July 30, 2024, does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous contracts by various...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,354.27 firm fixed price delivery order is for the provision of 4564221882 - GRALISE ER 300 MG TABLET 90S, a branded pharmaceutical product. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. This IDC...